Arena Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 62 U.S.-traded ETFs. ARNA has around 3.9M shares in the U.S. ETF market. The largest ETF holder of ARNA is the SPDR S&P Biotech ETF (XBI), with approximately 739.80K shares. Investors may also find of interest that the ETF with the largest allocation to ARNA stock is Amplify Seymour Cannabis ETF (CNBS), with a portfolio weight of 4.64%. On average, U.S. ETFs allocate 0.51% of ARNA to their portfolios.
Additionally, ARNA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ARNA as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 27.53%.